D.G. Illescas
Vall d'Hebron Hospital Universitari(ES)
Publications by Year
Research Areas
COVID-19 and healthcare impacts, COVID-19 Clinical Research Studies, Ovarian cancer diagnosis and treatment, Long-Term Effects of COVID-19, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry(2023)33 cited
- → 318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients(2020)12 cited
- → 741MO Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion(2023)4 cited
- → LBA42 Raludotatug deruxtecan (R-DXd) in patients (pts) with platinum-resistant ovarian cancer (PROC): Primary analysis of the phase II dose-optimization part of REJOICE-Ovarian01(2025)1 cited
- → 438P Real-world data of relapse after adjuvant treatment (Tx) in high-risk melanoma(2020)